Volume 15, Issue 3 (Volume 15, No3 2024)
jdc 2024, 15(3): 179-188 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Rostami Moghaddam M, Zandian H, Jafarzadeh M, Jodeiri Agaei A. Determining the frequency of telogen effluvium hair loss in female patients with covid-19 referred to Imam Reza hospital dermatology clinic at 2022. jdc 2024; 15 (3) :179-188
URL: http://jdc.tums.ac.ir/article-1-5746-en.html
URL: http://jdc.tums.ac.ir/article-1-5746-en.html
1- Department of Dermatology, Faculty of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran , rostamimajid665@gmail.com
2- Department of Dermatology, Faculty of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran
2- Department of Dermatology, Faculty of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran
Abstract: (46 Views)
Background and Aim: Telogen effluvium (TE) is a type of diffuse hair loss that occurs 2 to 3 months after a stressful event, including a covid-19 infection. The aim of this study was to determine the frequency of TE in women with covid-19.
Methods: This descriptive study was conducted on 270 women who referred to the skin and hair clinic of Imam Reza Ardabil Hospital with complaints of hair loss. Information related to the history of covid-19 infection, hospitalization, medications, vaccination and demographic characteristics were collected. The severity of alopecia was checked by clinical examination and traction test, and the data were analyzed with SPSS software.
Results: The average age of the patients was 41 years. 61.1% had a history of hospitalization, 43.7% used antibiotics, 61.8% used corticosteroids, and 51.8% used NSAID. The severity of Covid-19 had a significant relationship with the earlier occurrence of TE (P=0.001) and the increase in the number of pulled hairs in the traction test (P=0.001). Hospitalization due to covid-19 and corticosteroid use reduced the time between illness and onset of TE symptoms. The injection of AstraZeneca vaccine was associated with an increase in the number of plucked hairs (P=0.02).
Conclusion: The severity of TE was related to the severity of covid-19, hospitalization, corticosteroid use and injection of AstraZeneca vaccine.
Methods: This descriptive study was conducted on 270 women who referred to the skin and hair clinic of Imam Reza Ardabil Hospital with complaints of hair loss. Information related to the history of covid-19 infection, hospitalization, medications, vaccination and demographic characteristics were collected. The severity of alopecia was checked by clinical examination and traction test, and the data were analyzed with SPSS software.
Results: The average age of the patients was 41 years. 61.1% had a history of hospitalization, 43.7% used antibiotics, 61.8% used corticosteroids, and 51.8% used NSAID. The severity of Covid-19 had a significant relationship with the earlier occurrence of TE (P=0.001) and the increase in the number of pulled hairs in the traction test (P=0.001). Hospitalization due to covid-19 and corticosteroid use reduced the time between illness and onset of TE symptoms. The injection of AstraZeneca vaccine was associated with an increase in the number of plucked hairs (P=0.02).
Conclusion: The severity of TE was related to the severity of covid-19, hospitalization, corticosteroid use and injection of AstraZeneca vaccine.
Type of Study: Research |
Subject:
General
Received: 2024/12/29 | Accepted: 2024/11/5 | Published: 2024/11/5
Received: 2024/12/29 | Accepted: 2024/11/5 | Published: 2024/11/5
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
